Plasma N-Terminal Pro-B-Type Natriuretic Peptide Is Associated with Intrinsic Capacity Decline in an Older Population

被引:24
|
作者
Ma, Lina [1 ]
Zhang, Y. [1 ]
Liu, P. [1 ]
Li, S. [1 ]
Li, Y. [1 ]
Ji, T. [1 ]
Zhang, L. [1 ]
Chhetri, J. K. [2 ]
Li, Y. [1 ]
机构
[1] Capital Med Univ, Natl Res Ctr Geriatr Med, Dept Geriatr, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurol & Neurobiol, Beijing, Peoples R China
来源
JOURNAL OF NUTRITION HEALTH & AGING | 2021年 / 25卷 / 02期
基金
国家重点研发计划;
关键词
Intrinsic capacity; N-terminal pro-B-type natriuretic peptide; older adults; chronic inflammation; FRAILTY; ADULTS; INDEX;
D O I
10.1007/s12603-020-1468-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives To determine the association between plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) and intrinsic capacity in an older population. Method We recruited 283 participants aged 60 -/+ 97 years (mean 77.42 +/- 4.08 years). Intrinsic capacity was assessed with the World Health Organization Integrated Care for Older People (ICOPE) screening tool including six domains: cognition, locomotion, vitality, hearing, vision, and psychology. Multimorbidity, polypharmacy, gait speed, physical activity, lifestyles, and chronic inflammation were assessed. We used multivariate logistic regression and the Spearman's correlation to assess the association between plasma NT-proBNP and intrinsic capacity. Results The average intrinsic capacity score was 4.53 +/- 1.34. The percentage of decreased intrinsic capacity was 75.3%. Participants with decreased intrinsic capacity were older, with more cardiovascular and cerebrovascular diseases and polypharmacy, and had lower gait speed and higher C-reactive protein. Plasma NT-proBNP was significantly higher in the decreased intrinsic capacity group (128.0[56.8 -/+ 280.8] pg/mL vs. 72.6[39.7 -/+ 120.0] pg/mL, p<0.001). Multivariate logistic regression analysis revealed that NT-proBNP was the only independent risk factor for decreased intrinsic capacity among multiple covariates (odds ratio=1.005, p=0.038). Elevated NT-proBNP levels were associated with abnormal locomotion, hearing, vision, and psychology domains. Additionally, NT-proBNP levels were inversely correlated with the intrinsic capacity score adjusted for both age and coronary artery disease (r=-0.371, p< 0.001). Conclusion Elevated NT-proBNP levels were associated with decreased intrinsic capacity in older persons, independent of age, multimorbidity, polypharmacy, and chronic inflammation. Further longitudinal studies are required to explore the predictive role of NT-proBNP on declines in intrinsic capacity.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [41] Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia
    Staub, Daniel
    Jonas, Nils
    Zellweger, Michael J.
    Nusbaumer, Charly
    Wild, Damian
    Pfisterer, Matthias E.
    Mueller-Brand, Jan
    Perruchoud, Andre P.
    Mueller, Christian
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (11): : 1287.e9 - 1287.e16
  • [42] N-terminal pro-B-type natriuretic peptide is also related to increased mortality
    Golcuk, Yalcin
    Golcuk, Burcu
    Sozen, Semih
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (05): : 729 - 730
  • [43] N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization
    Sir, Jung-Ju
    Chung, Woo-Young
    Hwang, Seok-Jae
    Kang, Hyun-Jae
    Cho, Young-Seok
    Koo, Bon-Kwon
    Chae, In-Ho
    Choi, Dong-Ju
    Kim, Hyo-Soo
    Sohn, Dae-Won
    Kim, Cheol-Ho
    Oh, Byung-Hee
    Park, Young-Bae
    Choi, Yun-Shik
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 126 (03) : 322 - 332
  • [44] N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances
    Andreassen, Mikkel
    Faber, Jens
    Vestergaard, Henrik
    Kistorp, Caroline
    Kristensen, Lars Ostergaard
    CLINICAL ENDOCRINOLOGY, 2007, 66 (05) : 619 - 625
  • [45] N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL IN TYPE 2 DIABETIC PATIENTS
    Vasilkova, Volha
    Mokhort, Tatiana
    Zmailik, Margarita
    Naumenko, Elena
    JOURNAL OF HYPERTENSION, 2016, 34 : E438 - E438
  • [46] Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy
    Thaman, Rajesh
    Esteban, Maite Tome
    Barnes, Sophie
    Gimeno, Juan R.
    Mist, Bryan
    Murphy, Ross
    Collinson, Paul O.
    McKenna, William J.
    Elliott, Perry M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (04): : 515 - 519
  • [47] N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Renal Transplant Recipients Versus the General Population
    Oterdoom, Leendert H.
    de Vries, Aiko P. J.
    van Ree, Rutger M.
    Gansevoort, Ron T.
    van Son, Willem J.
    van der Heide, Jaap J. Homan
    Navis, Gerjan
    de Jong, Paul E.
    Gans, Reinold O. B.
    Bakker, Stephan J. L.
    TRANSPLANTATION, 2009, 87 (10) : 1562 - 1570
  • [48] Increased Plasma N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Hepatitis C Virus Infection
    Che, Wenliang
    Hu, Dayi
    Liu, Wenling
    Xu, Yawei
    Chen, Yisen
    Huang, Yunli
    Li, Lei
    Xiao, Jie
    Matsumori, Akira
    CIRCULATION, 2010, 122 (02) : E327 - E327
  • [49] Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease
    Ettinger, Stephen J.
    Farace, Giosi
    Forney, Scott D.
    Frye, Michelle
    Beardow, Andrew
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2012, 240 (02): : 171 - 180
  • [50] N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population
    Linssen, Gerard C. M.
    Bakker, Stephan J. L.
    Voors, Adriaan A.
    Gansevoort, Ron T.
    Hillege, Hans L.
    de Jong, Paul E.
    van Veldhuisen, Dirk J.
    Gans, Rijk O. B.
    de Zeeuw, Dick
    EUROPEAN HEART JOURNAL, 2010, 31 (01) : 120 - 127